Concord Medical Co., Ltd. (TPEX:6518)
26.00
0.00 (0.00%)
Feb 10, 2026, 12:06 PM CST
Concord Medical Revenue
Concord Medical had revenue of 448.81M TWD in the half year ending June 30, 2025, with 11.25% growth. This brings the company's revenue in the last twelve months to 905.31M, up 4.89% year-over-year. In the year 2024, Concord Medical had annual revenue of 889.85M with 6.80% growth.
Revenue (ttm)
905.31M
Revenue Growth
+4.89%
P/S Ratio
0.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
866.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 889.85M | 56.64M | 6.80% |
| Dec 31, 2023 | 833.20M | -56.00M | -6.30% |
| Dec 31, 2022 | 889.21M | 150.22M | 20.33% |
| Dec 31, 2021 | 738.99M | -70.72M | -8.73% |
| Dec 31, 2020 | 809.70M | 45.94M | 6.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.20B |
| Nang Kuang Pharmaceutical | 2.22B |
| Bionime | 1.91B |
| Chi Sheng Pharma & Biotech | 1.36B |
| ICARES Medicus | 1.09B |
| Crystalvue Medical | 905.73M |
| Maxigen Biotech | 792.49M |
| Unicon Optical | 747.16M |